3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
1
SCLC,Extensive Stage
1
Prostatic Neoplasms, Castration-Resistant
1
Ovarian Carcinosarcoma
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Metastatic Castration-sensitive Prostate Cancer
1
Laryngeal Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Ovarian Epithelial
1
Biliary Tract Neoplasms
1
Interventions
Rituximab
12
Cyclophosphamide
12
Biopsy
12
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
obinutuzumab
7
fludarabine
7
Lenalidomide
7
Prednisone
6
pembrolizumab
5
Nuclear Medicine Department, Hospital
5
fludarabine phosphate
4
X-Rays
4
Tacrolimus
4
Mycophenolic Acid
4
Doxorubicin
4
Busulfan
4
venetoclax
3
ibrutinib
3
glofitamab
3
acalabrutinib
3
Whole-Body Irradiation
3
Vincristine
3
GSK2636771
3
Etoposide
3
Bendamustine Hydrochloride
3
zanubrutinib
2
trametinib
2
tocilizumab
2
palbociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
niraparib
×
30 days
×
Clear all
No trials found.